Description

JUVÉDERM VOLBELLA with Lidocaine is a sterile cross-linked hyaluronic acid injectable gel implant manufactured by Allergan. It is intended for professional treatment of fine lines and medium-sized skin depressions and may also be used for authorised lip-related applications.

Each 1 ml syringe contains 15 mg of hyaluronic acid gel and 3 mg of lidocaine hydrochloride. A standard box contains two 1 ml prefilled syringes and four sterile, single-use 32G ½-inch needles.

What is JUVÉDERM VOLBELLA?

JUVÉDERM VOLBELLA is a professional facial filler within the JUVÉDERM collection. The product is a sterile, clear, physiological gel containing cross-linked hyaluronic acid of non-animal origin.

The official instructions identify fine lines and medium-sized skin depressions among its intended applications. The product may also be used for authorised lip enhancement and correction of certain structural concerns such as asymmetry, contour irregularity and volume loss.

Some regulatory markets also include specific professional use for infraorbital skin depressions. Authorised indications vary, and practitioners must follow the instructions included with the product being supplied.

JUVÉDERM VOLBELLA product specifications

• Product name: JUVÉDERM VOLBELLA with Lidocaine
• Product type: Cross-linked hyaluronic acid injectable gel implant
• Hyaluronic acid: 15 mg per 1 ml syringe
• Lidocaine hydrochloride: 3 mg per 1 ml syringe
• Lidocaine concentration: 0.3%
• Individual syringe volume: 1 ml
• Pack size: Two prefilled syringes
• Total gel volume: 2 ml
• Needles included: Four sterile 32G ½-inch single-use needles
• Manufacturer: Allergan
• Manufacturing location: France
• Product format: Sterile prefilled disposable syringe
• Intended user: Authorised and appropriately qualified medical practitioners

Key features of JUVÉDERM VOLBELLA

JUVÉDERM VOLBELLA contains a smooth cross-linked hyaluronic acid gel developed for applications requiring a softer product profile than structural volume fillers such as VOLUMA or VOLUX.

The product is presented in graduated, prefilled syringes. Each standard box also includes sterile needles, manufacturer instructions and traceability labels for recording the product and batch used for a patient.

VOLBELLA contains 0.3% lidocaine. The manufacturer includes this local anaesthetic to help reduce the patient’s pain during professional administration. Lidocaine does not eliminate all discomfort or procedural risk.

Hyaluronic acid and lidocaine

Hyaluronic acid: Each syringe contains 15 mg of cross-linked hyaluronic acid gel. Hyaluronic acid is used in absorbable filler products to provide temporary physical volume and support within the intended tissue.

Lidocaine hydrochloride: Each 1 ml syringe contains 3 mg of lidocaine hydrochloride. Patients must disclose any previous allergy or sensitivity to lidocaine or other amide local anaesthetics.

The formulation also contains a phosphate buffer adjusted to pH 7.2. Practitioners should consult the enclosed instructions for complete composition, contraindications, warnings and precautions.

VOLBELLA compared with other JUVÉDERM products

JUVÉDERM products have different gel properties, concentrations and intended professional applications:

• JUVÉDERM VOLBELLA: Contains 15 mg HA per 1 ml and is intended for fine lines, medium-sized depressions and authorised lip-related applications.
• JUVÉDERM VOLITE: Contains 12 mg HA per 1 ml and is intended for superficial skin depressions and skin-quality characteristics.
• JUVÉDERM VOLUMA: Contains 20 mg HA per 1 ml and is intended to restore facial volume.
• JUVÉDERM VOLUX: Contains 25 mg HA per 1 ml and is intended to restore and create facial volume.

These products are not interchangeable. The treating medical practitioner must select the appropriate formulation after assessing the patient and intended treatment area.

Professional consultation and assessment

JUVÉDERM VOLBELLA must only be administered by an authorised medical practitioner with appropriate anatomical knowledge, training, insurance and legal authority. It must not be self-injected or administered at home.

A professional consultation should review medical conditions, medication, allergies, previous injectable treatments, existing implants, skin condition and treatment expectations.

The official instructions identify contraindications that include known hypersensitivity to hyaluronic acid, lidocaine, amide local anaesthetics or relevant bacterial proteins. Additional restrictions apply to certain medical conditions and patient groups.

Potential risks, complications, alternatives and aftercare should be explained before treatment. Individual experiences and duration can vary, so no exact result should be guaranteed.

Important restrictions

The official instructions state that JUVÉDERM VOLBELLA must not be injected into the eyelids or blood vessels. The product should not be used to overcorrect a treatment area.

It must not be used in an area affected by active inflammation or infection. The instructions also contain precautions concerning laser treatments, chemical peels, dermabrasion and previous permanent implants.

This information is a general safety summary, not an injection protocol. The complete manufacturer instructions must be read and followed before professional use.

Packaging and authenticity checks

Inspect every JUVÉDERM VOLBELLA box before use. Confirm the product name, manufacturer, two-syringe presentation, batch number, expiry date, seals and traceability labels.

Do not use the product if the box, sterile packaging, syringe or needle packaging appears damaged, opened or altered. A product whose authenticity or storage history cannot be confirmed should not be administered.

Retain the invoice, original packaging, batch information and patient traceability labels. These records may be required if a product complaint or safety incident needs to be investigated.

Storage and responsible handling

Store JUVÉDERM VOLBELLA according to the conditions printed on its original packaging and instructions. Keep it sealed, protected from unsuitable environmental conditions and secured against unauthorised access.

Each syringe and needle is intended for single-patient use. Opened, used, damaged or expired products must be disposed of according to applicable infection-control, sharps and clinical-waste procedures.

Important regulatory information

This page provides general commercial product information. It is not medical advice, an injection guide or confirmation that every international indication applies in the United Kingdom.

Purchasers are responsible for verifying authenticity, conformity marking, regulatory status and permitted use. Professionals must read and follow the instructions supplied with their specific product.

For complete manufacturer information, review the official JUVÉDERM VOLBELLA instructions for use. You can also browse other professional products from The Clinic Vault shop.

Order JUVÉDERM VOLBELLA

A standard box contains two 1 ml prefilled syringes and four sterile 32G ½-inch needles. Before ordering, confirm that the packaging, regional version, expiry date and conformity information meet your professional requirements.

Add JUVÉDERM VOLBELLA to your basket when ready, or contact The Clinic Vault for clarification about availability or packaging. This medical device is supplied for authorised professional use and must not be self-administered.